Genea Biocells’ senior scientist Dr Leslie Caron is presenting along with a stellar line up of Australian muscle researchers at the upcoming NSW Stem Cell Network workshop Stem Cells and Genetic Muscle Disorders.
The workshop brings together Australia’s top skeletal and cardiac muscle researchers to explore current and future applications of stem cells to muscle disease therapies. The viability of treatment options to each disease will be discussed including the contribution of muscle stem cells to muscle diseases, progress in transplantation therapies and the use of pluripotent cell models for screening and scalable cellular therapies.
Confirmed speakers include former senior Macquarie Bank executive and FSHD Global Research Foundation founder and chairman Bill Moss (FSHD Global), Professor Miranda Grounds (UWA), Dr James Chong (WCH), Professor Peter Currie (ARMI) and Professor Paul Gregorovic (Baker IDI).
Through a partnership with FSHD Global, Genea Biocells developed a process for production of human pluripotent cell derived skeletal muscle. The three step protocol generates a highly pure population of approximately 70 per cent skeletal muscle myotubes in just 28 days. This innovation is spurring new interest in a field that has long been dependent on suboptimal invasive muscle biopsies and is being used by world leading researchers in Europe and the USA.